Kangaroo position for preterm infants on oxygen therapy
Kangaroo Position in Preterm Newborn Infants Under Oxygen Therapy
This study tests if holding preterm babies in the kangaroo position while they get oxygen therapy can help them feel better and stabilize their health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 2 Days to 28 Days |
| Sex | All |
| Sponsor | Universidade Metodista de Piracicaba Academic / other |
| Locations | 1 site (Belém, Pará) |
| Trial ID | NCT06170892 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of the kangaroo position on preterm newborns who require supplemental oxygen therapy. The kangaroo method aims to enhance emotional bonding and stabilize vital signs, including respiratory comfort and body temperature. Newborns will be assessed before, during, and after being placed in the kangaroo position to quantify its impact on their health. The study seeks to provide scientific evidence for the benefits of this method in a clinical setting.
Who should consider this trial
Good fit: Ideal candidates are preterm newborns aged 28 to 36 weeks and 6 days who are less than 28 days old and require supplemental oxygen.
Not a fit: Patients with neuromuscular diseases, congenital heart disease, or those on mechanical ventilation may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could improve the respiratory comfort and overall health outcomes of preterm infants undergoing oxygen therapy.
How similar studies have performed: While the kangaroo method is widely used, this specific application in preterm infants on oxygen therapy is relatively novel and lacks extensive prior evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * newborns with a gestational age of 28 to 36 weeks and 6 days, * up to twenty-eight days of life; * using supplemental circulating oxygen Exclusion Criteria: * neuromuscular disease; * intracranial hypertension; * intracranial hemorrhage; * congenital heart disease * pneumothorax; * pneumatocele; * active bleeding; * mechanical ventilation
Where this trial is running
Belém, Pará
- Universidade do Estado do Pará — Belém, Pará, Brazil (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.